Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2000

View Archived Issues

Genetic basis of preeclampsia identified by Pittsburgh researchers

BioChem Pharma presents overview of recent company progress

IGI and Fujisawa collaborate on topical formulations of dermatological product

Efavirenz tested in combination regimens against HIV-1

Genentech continues to move products smoothly through the pipeline

Combination efavirenz, nelfinavir and NRTIs assessed in children with HIV-1

Alza and Abbott formally terminate merger agreement

U.S. patent for HCV vaccine granted to Innogenetics

Generex presents latest results for oral insulin formulation

Ophidian highlights development efforts for fiscal first quarter

International research team establishes leptin-brain-bone mass link

New study will evaluate Remune plus HAART in early-stage HIV

Enzon describes pegylated prodrugs of antitumor compounds with increased water solubility

Novel MCP-1 antagonists emerge from Warner-Lambert research

Baxter acquires rights to Xoma's Neuprex for meningococcemia

Delta receptor ligands with potential as analgesics under study at AstraZeneca

Glaxo Wellcome investigates therapeutic potential of biaryl derivatives

Antiarrhythmic compounds with improved safety synthesized at Mitsui Chemicals

Takeda files for ED treatment in Europe

FDA allows NicOx to begin phase I trials of NO-NSAID

Eisai team identifies promising new selective RARalpha agonist

Dendreon initiates patient enrollment in phase III prostate cancer study

Novel CDK4 inhibitor series available for licensing from NIH

West soon to initiate phase I testing of nasal morphine in U.S.

Searle initiates survival study of aldosterone antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026